Free Phlebotomy Exam Questions That Helps Candidates Pass

Order of draw prevents additive carryover that can alter test results. Whether using an evacuated system or transferring from a syringe via a safety device, the sequence remains the same: blood cultures first (to minimize contamination), then sodium citrate (light blue) for coagulation (preserving the 9:1 ratio), followed by serum tubes, heparin (green), EDTA (lavender/pink), and glycolytic inhibitor (gray). Option C reflects this standard. Reversing the order risks EDTA carryover (falsely low calcium, falsely high potassium) or clot activator contamination affecting coagulation tests. Option D is incorrect—device choice does not change biochemical interactions between additives. During transfer, allow the tube’s vacuum to draw blood (do not force with the syringe plunger) and gently invert each tube as labeled. This maintains specimen integrity, ensures valid results, and aligns with widely taught preanalytical guidelines.

For semen analysis, motility and morphology are time- and temperature-sensitive. Patients are typically instructed to abstain from ejaculation for ~2–7 days before collection, collect by masturbation into a sterile, wide-mouth container without lubricants or condoms (unless using a lab-approved, non-spermicidal collection condom), and keep the specimen near body temperature—e.g., carried in an inner pocket—delivering it to the laboratory within about one hour. Option B captures the critical temperature and timing. Lubricants (Option A) and most condoms contain spermicidal agents or additives that impair motility. Daily ejaculation (Option C) can reduce sperm count and motility, compromising interpretation. Refrigeration (Option D) depresses motility and is inappropriate for routine analysis unless specifically directed by the lab for certain tests. Clear written instructions, documentation of collection time, and avoidance of incomplete samples (loss of initial fraction) are essential to analytic validity and are frequently assessed in non-blood specimen competencies.

Whole-blood citrate specimens for coagulation testing are typically maintained at room temperature and analyzed within the laboratory’s validated window (commonly ≤4 hours for PT and shorter for some aPTT methods) unless plasma is separated and frozen per policy. Refrigeration or chilling whole blood can induce cold activation of platelets and factor changes (e.g., von Willebrand factor/platelet activation) that artifactually alter clot times. Therefore, do NOT place unprocessed citrate tubes on ice or in the refrigerator. Mix by gentle inversion at collection, transport promptly upright, and avoid excessive agitation. If delays are unavoidable, coordinate with the lab to prepare platelet-poor plasma and freeze according to guidelines. Option B reflects these principles. Options A, C, and D risk preanalytical alteration of coagulation factors. Adhering to tube fill (9:1 ratio), avoidance of hemolysis, and timely processing preserves result integrity—a common certification topic.

Fibrin strands indicate incomplete clotting prior to centrifugation. Residual fibrin can clog probes, cause sample aspiration errors, and trap analytes or cells, leading to erroneous results and analyzer downtime. The correct response is to follow lab policy: re-centrifuge if validated to settle remaining fibrin; if contamination persists or the specimen was spun prematurely, request recollection ensuring a full clot time (≈30 minutes for standard SST; shorter for validated rapid thrombin tubes). Option C addresses both prevention and remediation. Fishing out clots (Option B) cannot guarantee uniformity and risks contamination. Ignoring (Option A) invites instrument issues and poor data. Vigorous shaking (Option D) hemolyzes the sample and exacerbates problems. Document preanalytical issues and coach collectors on proper clotting, gentle inversions, and time stamps. Preventing fibrin is a high-yield processing competency on certification exams.

Anticoagulated patients (e.g., on warfarin, DOACs) have an elevated risk of prolonged bleeding and hematoma. After removing the needle, apply firm, direct pressure with clean gauze for an extended period—commonly at least 5 minutes—and recheck the site before dressing. Option A reflects safe practice. A quick bandage (Option B) without verifying hemostasis invites delayed bleeding under the dressing. Bending the arm (Option C) can dislodge the clot and conceal bleeding; straight-arm pressure is preferred. Ice (Option D) may reduce superficial oozing but is not a substitute for sustained compression and observation. Additional precautions include using the smallest appropriate gauge, avoiding high-risk sites (e.g., basilic vein near artery/nerve), limiting attempts, and educating the patient to report recurrent bleeding and to avoid heavy lifting with the arm for several hours. Document prolonged hemostasis time per policy. These steps align with safety objectives and help prevent complications such as large hematomas or compartment syndrome.